Table 2.
Overall survival rate (OS) in the CIK cell treatment group and conventional treatment group.
| Study | CIK cell treatment OS (%) | Total | Conventional treatment OS (%) | Total |
|---|---|---|---|---|
| 1-Year | ||||
| Jiang, 2006 | 16 (51) | 32 | 12 (48) | 25 |
| Shi, 2012 | 73 (98) | 74 | 73 (95) | 77 |
| Liu, 2013 | 50 (98) | 51 | 44 (93.6) | 47 |
| Gao, 2014 | 25 (93) | 27 | 21 (79) | 27 |
| 2-year | ||||
| Jiang, 2006 | 13 (40) | 32 | 9 (38) | 25 |
| Jiang, 2010 | 55 (73.5) | 75 | 43 (52.6) | 81 |
| Liu, 2013 | 47 (92.2) | 51 | 37 (78.7) | 47 |
| 3-year | ||||
| Jiang, 2006 | 4 (11) | 32 | 3 (12) | 25 |
| Shi, 2012 | 50 (67.7) | 74 | 42 (54.5) | 77 |
| Liu, 2013 | 37 (72.5) | 51 | 28 (59.6) | 47 |
| Zhao, 2013 | 33 (62.3) | 53 | 52 (46.4) | 112 |
| Gao, 2014 | 22 (82) | 27 | 11 (42) | 27 |
| 5-year | ||||
| Jiang, 2010 | 30 (40.4) | 75 | 19 (23.9) | 81 |
| Shi, 2012 | 24 (32.4) | 74 | 18 (23.4) | 77 |
| Zhao, 2013 | 30 (56.6) | 53 | 30 (26.8) | 112 |
| Gao, 2014 | 18 (66) | 27 | 9 (34) | 27 |